Psoriatic arthritis successfully treated with second-line anti-interleukin-6 treatment: a case report and review of the literature 

BACKGROUND: Psoriatic arthritis treatment with antitumor necrosis factor has been shown to reduce disease activity. Nonetheless, more than 30% of patients do not achieve a sufficient response to tumor necrosis factor blockers. Currently, treatment with interleukin-6 inhibitors is expected to be effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutsuna, Tatsuhiko, Hino, Kazunori, Hasegawa, Hitoshi, Watamori, Kunihiko, Kidani, Teruki, Imai, Hiroshi, Miura, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632098/
https://www.ncbi.nlm.nih.gov/pubmed/36324145
http://dx.doi.org/10.1186/s13256-022-03624-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632098/
https://www.ncbi.nlm.nih.gov/pubmed/36324145
http://dx.doi.org/10.1186/s13256-022-03624-z

Ejemplares similares